Michael Scolaro

Michael Scolaro

Nov 29, 2017

Group 6 Copy 203
0
References
  • 1. https://www.ncbi.nlm.nih.gov/pubmed/26558876
  • 2. https://www.ncbi.nlm.nih.gov/pubmed/26558876
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Community-based Leishmaniasis research in Sri Lanka

Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

Can we make anesthesia for dogs safer with the help of nutrition?

Hypothermia, low body temperature, is one of the most common complications of anesthesia and can result...

Why does our body produce one of the most potent hallucinogens?

Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings...

Backer Badge Funded